Effect of cimetidine on hepatotoxicity induced by isoniazid-rifampicin combination in rabbits

Indian Journal of Gastroenterology

Volumn 26, Issue 1, 2007, Pages 18-21

  Kalra, Bhupinder Singh ^a,b   Aggarwal, Sarita ^a   Khurana, Nita ^a   Gupta, Usha ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CIMETIDINE; ISONIAZID; LIVER ENZYME; RIFAMPICIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; DRUG POTENTIATION; ENZYME BLOOD LEVEL; FEMALE; FOOD INTAKE; LIVER HISTOLOGY; LIVER PROTECTION; LIVER TOXICITY; LIVER WEIGHT; MALE; MONOTHERAPY; NONHUMAN; RABBIT;

ANIMALS; ANTITUBERCULAR AGENTS; CIMETIDINE; HEPATITIS, TOXIC; HISTAMINE H2 ANTAGONISTS; ISONIAZID; LIVER FUNCTION TESTS; RABBITS; RIFAMPIN; STATISTICS, NONPARAMETRIC;

EID: 34248194220     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Lal S, Singhal SN, Burley DM, Crossley G. Effect of rifampicin and INH on liver function. Br Med J 1972;1:148-50.
2. Thomas BH, Wong LT, Zeitz W, Solomonraj G. Isoniazid metabolism in the rabbit, and the effect of rifampin pretreatment. Res Commun Chem Pathol Pharmacol 1981;33:235-47.
3. Noda A, Hsu KY, Noda H, Yamamoto Y, Kurozumi T. Is isoniazid- hepatotoxicity induced by the metabolite, hydrazine? J UOEH 1983;5:183-90.
4. Ellard GA, Gammon PT. Pharmacokinetics of isoniazid metabolism in man. J Pharmacokinet Biopharm 1976;4:831-13.
5. Al-Mustafa ZH, Al-Ali AK, Qaw FS, Abdul-Cader Z. Cimetidine enhances hepatoprotective action of N-acetylcysteine in mice treated with toxic doses of paracetamol. Toxicology 1997;121:223-8.
6. Ali BH, Al-Qarawi A, Mousa HM. Effect of grapefruit juice and cimetidine on the concentration of chloroquine in plasma of chickens. Indian J Pharmacol 2001;33:289-90.
7. Sztajnkrycer MD, Otten EJ, Bond GR, Lindsell CJ, Goetz RJ. Mitigation of pennyroyal oil hepatotoxicity in the mouse. Acad Emerg Med 2003;10:1024-8.
8. Sarich TC, Zhou T, Adams SP, Bain AI, Wall RA, Wright JM. A model of isoniazid-induced hepatotoxicity in rabbits. J Pharmacol Toxicol Methods 1995;34:109-16.
9. Gowenlock AH. Varley's Practical Clinical Biochemistry, 6th ed. New Delhi: CBS Publishers. 2002.
10. Bailey WC, Taylor SL, Dascomb HE, Greenberg HB, Ziskind MM. Disturbed hepatic function during isoniazid chemoprophylaxis. Monitoring the hepatic function of 427 hospital employees receiving isoniazid chemoprophylaxis for tuberculosis. Am Rev Respir Dis 1973;107:523-9.
11. Lesobre R, Ruffino J, Teyssier L, Achard F, Brefort G. Jaundice occurring during treatment with rifampicin. Rev Tuberc 1969;33:393-403.
12. Cross FS, Long MW, Banner AS, Snider DE Jr. Rifampin-isoniazid therapy of alcoholic and nonalcoholic tuberculous patients in a U.S. Public Health Service Cooperative Therapy trial. Am Rev Respir Dis 1980;122:349-53.
13. Mitchell JR, Zimmerman HJ, Ishak KG, Thorgeirsson UP, Timbrell JA, Snodgrass WR, et al. Isoniazid liver injury: clinical spectrum, pathology and probable pathogenesis. Ann Intern Med 1976;84:181-92.
14. Sodhi CP, Rana S, Mehta S, Vaiphei K, Attari S, Mehta S. Study of oxidative stress in rifampicin-induced hepatic injury in young rats. Drug Chem Toxicol 1997;20;255-69.
15. Mitchell MC, Schenker S, Avant GR, Speeg KV Jr. Cimetidine protects against acetaminophen hepatotoxicity in rats. Gastroenterology 1981;81:1052-60.